Upgrade to SI Premium - Free Trial

Corvus Pharma (CRVS)

13.62 -0.37 (2.64%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Form 8-K Corvus Pharmaceuticals, For: Jul 21 July 22, 2026 4:02 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Moore David Scott June 15, 2026 5:12 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: CLARK IAN T June 15, 2026 5:10 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Grais Linda June 15, 2026 5:08 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Thompson Peter A. June 15, 2026 5:07 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: van den Broek Richard June 15, 2026 5:04 PM - SEC Filing Form 8-K Corvus Pharmaceuticals, For: Jun 11 June 12, 2026 4:01 PM - SEC Filing Corvus Pharmaceuticals invests $5 million in Angel Pharmaceuticals June 9, 2026 7:30 AM - StreetInsider Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China June 9, 2026 7:30 AM - Globe NewsWire Form 4 Corvus Pharmaceuticals, For: May 18 Filed by: MILLER RICHARD A MD May 20, 2026 4:12 PM - SEC Filing Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference May 20, 2026 4:01 PM - Globe NewsWire Form SCHEDULE 13G/A Corvus Pharmaceuticals, Filed by: Point72 Asset Management, L.P. May 15, 2026 4:20 PM - SEC Filing Form SCHEDULE 13G Corvus Pharmaceuticals, Filed by: Sirenia Capital Management LP May 15, 2026 8:11 AM - SEC Filing Corvus Pharmaceuticals (CRVS) Reiterated at Overweight by Cantor Fitzgerald May 15, 2026 7:33 AM - StreetInsider Form 8-K Corvus Pharmaceuticals, For: May 14 May 14, 2026 7:01 AM - SEC Filing Corvus Pharmaceuticals presents soquelitinib atopic dermatitis data May 14, 2026 7:00 AM - StreetInsider Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting May 14, 2026 7:00 AM - Globe NewsWire Form S-8 Corvus Pharmaceuticals, May 7, 2026 5:03 PM - SEC Filing Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q1 EPS May 7, 2026 4:24 PM - StreetInsider Form 10-Q Corvus Pharmaceuticals, For: Mar 31 May 7, 2026 4:06 PM - SEC Filing Form 8-K Corvus Pharmaceuticals, For: May 07 May 7, 2026 4:02 PM - SEC Filing Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results May 7, 2026 4:01 PM - Globe NewsWire Form 3 Corvus Pharmaceuticals, For: Apr 23 Filed by: Chan Andrew C. April 27, 2026 5:33 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Apr 23 Filed by: Chan Andrew C. April 27, 2026 5:33 PM - SEC Filing Form SCHEDULE 13G/A Corvus Pharmaceuticals, Filed by: BlackRock, Inc. April 27, 2026 4:15 PM - SEC Filing Form DEFA14A Corvus Pharmaceuticals, April 24, 2026 4:18 PM - SEC Filing Form DEF 14A Corvus Pharmaceuticals, For: Jun 11 April 24, 2026 4:16 PM - SEC Filing Full Article List